ALPCO recently announced its partnership with InSphero, AG to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. InSphero’s 3D InSight™ Diabetes Discovery Platform offers users a comprehensive beta-cell function application suite with all required materials to quantify insulin secretion from 3D InSight™ Islet Microtissues, including ALPCO’s validated STELLUX® Chemiluminescent Insulin ELISA. InSphero Group Head […]

La Vista, NE – Streck, Inc. and Cromoion SRL, a distributor of human and veterinary diagnostic products in Argentina, have signed a three-year distribution agreement for Streck’s full portfolio of controls, cell stabilization and molecular products. Streck’s cell stabilization products include Cyto-Chex® BCT, a blood collection tube for the preservation of whole blood specimens for […]

Torrance, Calif. – Phenomenex Inc., global leader in the research, design and manufacture of advanced technologies for the separation sciences, announces a new Luna Omega phase for sugar analysis by hydrophilic interaction chromatography (HILIC). Luna Omega SUGAR is specifically engineered for carbohydrate separation and analysis from food, beverage and pharmaceutical matrices, such as milk, animal feed, […]

Torrance, Calif. – Phenomenex Inc., global leader in the research, design and manufacture of advanced technologies for the separation sciences, announces a new Luna Omega phase for sugar analysis by hydrophilic interaction chromatography (HILIC). Luna Omega SUGAR is specifically engineered for carbohydrate separation and analysis from food, beverage and pharmaceutical matrices, such as milk, animal feed, […]

AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications. The latest tool in genome science – CRISPR/Cas9 is a simple and efficient genome editing tool which allows for specific genome disruption and replacement resulting in high specificity and low cell toxicity. AMSBIO CRISPR Complete kits are […]

High-throughput spheroid microplate benefits cancer research, drug screening CORNING, N.Y. – Corning Incorporated (NYSE: GLW) has expanded its spheroid microplate product offerings with the introduction of a unique 1536-well plate designed specifically for growing spheroid cell cultures. The Corning® 1536-well Spheroid Microplate helps scientists generate a higher volume of spheroids for high-throughput screening, which is especially beneficial in cancer research and […]

Easy to use: The large touchscreen and intuitive onboard software simplify programming, operation and data visualization. Runs most common assays: Nucleic acid and protein quantification in microplates or 2 µL samples with the Take3 Plate, ELISA, cell viability, gene expression and more. Excellent performance: Synergy LX offers uncompromised performance for UV-Vis absorbance, fluorescence and luminescence assays. Budget-friendly: At nearly half the price of […]

(ANN ARBOR, Mich.) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced early access to its Swift 2S Turbo Library Kit. These new kits offer a fast, robust enzymatic fragmentation prep and flexible adapter options to produce high-quality libraries for production-scale sequencing. With an automation friendly workflow, the Swift […]

MONTREAL’S MÉDIMABS TO DISTRIBUTE REAGENT ANTIBODIES TO INTERNATIONAL MARKET Toronto, ON, Canada – The Centre for the Commercialization of Antibodies and Biologics (CCAB) and MédiMabs Antibodies have signed an agreement for the distribution of CCAB’s reagent antibodies. The agreement marks the launch of a new business segment for CCAB and allows MédiMabs to expand its portfolio to include human synthetic […]

SAN FRANCISCO — Enable Biosciences Inc was awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant for $750,000 to commercialize ultrasensitive and multiplexable immunoassays for both research and clinical diagnostic use. Over 70% of clinical decisions are informed by lab tests, many of which rely on detecting antibody biomarkers. “For hundreds of infectious and autoimmune diseases and cancer, early […]